Erratum

Abstract

European Journal of NeurologyEarly View ERRATUMFree Access Erratum This article corrects the following: Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Carlo Lovati, Davide Bertuzzo, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Francesca Schiano Di Cola, Angelo Ranieri, Bruno Colombo, Francesco Bono, Maria Albanese, Sabina Cevoli, Piero Barbanti, , Giulia Pierangeli, Chiara Capogrosso, Marco Aguggia, Daniele Spitaleri, Stefano Messina, Francesca Trogu, Fabio Frediani, Ottavia Baldi, Renata Rao, Gennaro Alfieri, Roberta Messina, Massimo Filippi, Fabio Bombardieri., Volume 29Issue 4European Journal of Neurology pages: 1198-1208 First Published online: December 6, 2021 First published: 10 March 2023 https://doi.org/10.1111/ene.15757AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat In the article by Vernieri et al. [1], the affiliation of co-author, Alberto Doretti, was published as: 7Department of Neurology, Stroke Unit and Laboratory of Neuroscience, Italian Auxological Institute, Scientific Institute for Research and Health Care, Milan, Italy. The correct affiliation should be: 7Department of Neurology, Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, Scientific Institute for Research and Health Care, Milan, Italy. We apologize for this error. REFERENCE 1Vernieri F, Altamura C, Brunelli N, et al. Rapid response to galcanezumab and predictive factors in chronic migraine patients: a 3-month observational, longitudinal, cohort, multicenter, Italian real-life study. Eur J Neurol. 2022; 29: 1198- 1208. doi:10.1111/ene.15197 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation